Ketamine advertisements are popping up all around us. With few regulations in place, might we be witnessing another opioid epidemic?

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

Ketamine was first approved by the FDA as an anaesthetic in the 1970s and has been used for a long time in emergency and surgical settings. In 2019, esketamine (Spravato), derived from ketamine ...

However, it may cover Spravato, which contains esketamine. This is an FDA-approved drug that derives from ketamine and can help manage treatment-resistant depression. Despite not yet having FDA ...

Musk has said he uses ketamine regularly, so for the past couple of years, public speculation has persisted about how much he ...

The nasal variant of ketamine, esketamine, was developed by Johnson & Johnson Pharmaceuticals under the name brand Spravato; it’s the only type of ketamine approved by the FDA for treatment ...

Cybin (CYBN) stock earns Guggenheim's Buy rating with a $35 target, as the firm cites blockbuster potential for CYB003 in line with J&J's (JNJ) Spravato. Read more here.

Avesta's fourth location in Columbia, MD providing Ketamine Infusion Therapy and Spravato treatments for patients suffering from Treatment Resistant Depression, General Anxiety Disorder ...

Ketamine is often viewed more as a party drug than a medicine. One Columbia clinic is using the drug to help patients with ...

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...